CVRx Inc (CVRX)
CVRx Inc is a commercial-stage medical device company focused on neuromodulation solutions for people with cardiovascular disease. The company develops, manufactures, and commercializes Barostim, an implantable system that delivers electrical pulses to baroreceptors in the carotid artery wall and is designed to support baroreflex activation therapy, which connects the cardiovascular and autonomic nervous systems. CVRx sells its products in the United States, Germany, and other international markets through a direct sales force, sales agents, and independent distributors. Incorporated in 2000, the company is headquartered in Minneapolis, Minnesota. CVRx common stock is listed on NASDAQ under the ticker CVRX.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-CVRX
|
$6.50
|
34.8% Upside
|
Undervalued
|
$11.17
|
131.7% Upside
|
Bargain
|
Fair
|
—
|
—
|
—
|
0.0%
|
August 4, 2026
|
-2.4x
|
4.4x
|
2.2x
|
126.6 M
|
116.1 M
|
31.9%
|
69.1%
|
-7.4
|
—
|
76.3%
|
